The elevated CBL levels, in turn, exert an inhibitory effect on the activation of the Wnt/β-catenin signaling pathway, thus stalling the progression of papillary thyroid carcinoma (PTC) (Kamei et al., 2000). This evidence concerns the gene CBL and differentiated thyroid carcinoma.